arsenic trioxide has been researched along with Disease, Pulmonary in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Y; Gao, L; Liu, Y; Ma, D; Xue, J; Yao, C; Zhang, Z | 1 |
| Au, WY; Han, L; Ho, JC; Ip, MS; Kwong, YL | 1 |
| Gnadler, M; Hecht, A; Lengfelder, E; Mezger, J | 1 |
| Alimoghaddam, K; Ghavamzadeh, A; Jahani, M | 1 |
1 trial(s) available for arsenic trioxide and Disease, Pulmonary
| Article | Year |
|---|---|
Resveratrol ameliorates the oxidative damage induced by arsenic trioxide in the feline lung.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Analysis of Variance; Animals; Arsenic Trioxide; Arsenicals; Cat Diseases; Cats; Deoxyguanosine; Female; Gene Expression Regulation, Enzymologic; Lung Diseases; Male; Oxidative Stress; Oxides; Reactive Oxygen Species; Resveratrol; Stilbenes | 2013 |
3 other study(ies) available for arsenic trioxide and Disease, Pulmonary
| Article | Year |
|---|---|
Effect of therapeutic arsenic exposure on pulmonary function.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Case-Control Studies; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Forced Expiratory Volume; Humans; Leukemia, Promyelocytic, Acute; Lung Diseases; Male; Middle Aged; Oxides; Uteroglobin; Vital Capacity | 2013 |
[Very Severe Differentiation Syndrome in Low Risk Acute Promyelocytic Leukemia - A Peril of Differentiating Therapy].
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Diagnosis, Differential; Dyspnea; Female; Fever; Humans; Hypotension; Leukemia, Promyelocytic, Acute; Leukocytosis; Lung Diseases; Oxides; Risk Factors; Severity of Illness Index; Syndrome; Treatment Outcome; Tretinoin | 2017 |
Use of Novoseven for arsenic trioxide-induced bleeding in PML.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Factor VII; Factor VIIa; Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Lung Diseases; Oxides; Recombinant Proteins | 2006 |